Medtronic Stock News

Medtronic (NYSE: MDT) is scheduled to report its fiscal 2025 first-quarter results on Tuesday, August 20 (fiscal year ends in April). We expect Medtronic stock to trade higher post-Q1 results announcement, with its revenues and earnings expected to be slightly above the street estimates.

GALWAY, Ireland , Aug. 16, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 15, 2024, approved the company's cash dividend for the second quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024.

Although the market may have hit a calm relative to the wild volatility witnessed earlier this month, we may not be out of the woods yet. Sure, the CBOE Volatility Index or the VIX has come down significantly from its earlier highs.

GALWAY, Ireland , Aug. 12, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its first quarter of fiscal year 2025 on Tuesday, August 20, 2024. A news release will be issued at approximately 5:45 a.m.

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN , Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) — the company's first disposable, all-in-one CGM that's half the siz...

“Dividend Aristocrats… in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years.“- Kiplinger.. 67 Aristocrats, screened as of August 2, 2024, represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 8.12%-27.1% topped by CVX & TGT.

In July, we (my wife and I) received a dividend income total of $2,836.82. 2023 was up 24%. 7 months down in 2024 and the S&P 500 is still up almost 13%, despite the recent sell-offs. We have a high likelihood of a rate cut in September, but too much speculation is happening beyond that date. Time is ticking on that FOMC meeting.

Merck is finding ways to avoid a fast-approaching patent cliff by continuing to do what it's done for a while. Medtronic is a diversified healthcare giant with several important long-term growth catalysts.